Irish patients excluded from drug trials for life-saving treatments due to barriers
Ireland attracting fewer clinical trials than some European countries
Ireland attracting fewer clinical trials than some European countries
Just half of 41 cancer drugs approved from 2017-2020 were available here at end of 2021
Upfront costs high but treatments may cut long-term expense and boost patient results
Canada, Japan and South Korea warn against grab for vaccine supplies
State’s lack of a clear budget structure for medicines is a frustration for Big Pharma
Pharma group says eight cancer therapies awaiting HSE approval for over 900 days
Companies say they are working actively to prepare for worst-case Brexit scenario
Irish industry’s chief looks for partnership as he admits trust is lacking
Pharmaceutical sector urges faster access to markets and sharper focus on innovation
Government to save €15m this year as prices fall across 750 drugs
Cancer drugs feature in list of therapies waiting HSE approval on cost grounds
Drug companies told there is no budget and no plans for supplementary health budget
Cantillon: while Orkambi has been approved, nine other vital drugs are stalled in system
The drug giant’s point man in Ireland talks about acquisitions, setbacks, prices and Trump
Price drop is first under pricing deal signed by Government and Irish Pharmaceutical Healthcare Association
Annual savings of €78.4m predicted as result of agreement with drugs manufacturers
Drug manufacturers’ lobby group Ipha urges caution over study of competing treatments
Crosswords & puzzles to keep you challenged and entertained
Full general election coverage including analysis and results for all 43 constituencies
How does a post-Brexit world shape the identity and relationship of these islands
Weddings, Births, Deaths and other family notices